Profil
Dr. Michael Häggman is an Independent Director at Prostatype Genomics AB, an Associate Professor-Urology at Uppsala University Hospital, a Deputy Director at Kardinaltalet AB and a General Partner at Skrotum Kommanditbolag.
He is on the Board of Directors at Prostatype Genomics AB and Chundsell Medicals AB.
Aktive Positionen von Michael Häggman
| Unternehmen | Position | Beginn |
|---|---|---|
| PROSTATYPE GENOMICS AB | Direktor/Vorstandsmitglied | 01.01.2018 |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Direktor/Vorstandsmitglied | - |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | - |
Skrotum Kommanditbolag | Corporate Officer/Principal | - |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Chundsell Medicals AB
Chundsell Medicals AB BiotechnologyHealth Technology Develops and markets novel molecular diagnostics for the treatment of cancer | Health Technology |
Kardinaltalet AB
Kardinaltalet AB Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Prostatype Genomics AB
Prostatype Genomics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets prognostic genetic test prostatype equipment | Health Technology |
Skrotum Kommanditbolag |
















